Published in N Engl J Med on March 20, 1975
Cell-mediated immunity during syphilis. Br J Vener Dis (1978) 2.70
Host resistance in sepsis and trauma. Ann Surg (1975) 2.56
Depression of lymphocyte response to concanavalin A in rabbits infected with Treponema pallidum (Nichols strain). Infect Immun (1976) 2.00
Immune response to persistent mycobacterial infection in mice. Infect Immun (1978) 1.96
Cell-mediated immunity during natural measles infection. J Clin Invest (1978) 1.93
Viruses disrupt functions of human lymphocytes. Effects of measles virus and influenza virus on lymphocyte-mediated killing and antibody production. J Exp Med (1984) 1.92
Suppressor T-cells in BCG-infected mice. Infect Immun (1979) 1.88
Selective response of lymphocytes from Treponema pallidum-infected rabbits to mitogens and Treponema reiteri. Infect Immun (1977) 1.58
Selective in vitro response of thymus-derived lymphocytes from Treponema pallidum-infected rabbits. Infect Immun (1977) 1.53
The specificity of suppressor T cells induced by chronic Mycobacterium avium infection in mice. Clin Exp Immunol (1981) 1.42
Mucopolysaccharidase of Treponema pallidum. Infect Immun (1979) 1.35
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Different effects of influenza virus, respiratory syncytial virus, and Sendai virus on human lymphocytes and macrophages. Infect Immun (1982) 1.19
Development of suppressor T-cells in Mycobacterium habana-infected mice. Infect Immun (1979) 1.12
Inability of spleen cells from chancre-immune rabbits to confer immunity to challenge with Treponema pallidum. Infect Immun (1977) 1.11
Increased susceptibility to bacterial infection as a sequela of exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Infect Immun (1975) 1.11
PPD and mitogen responsiveness of lymphocytes from patients with atopic dermatitis. Clin Exp Immunol (1977) 1.08
Strain variation of bacillus Calmette-Guerin-induced pulmonary granuloma formation is correlated with anergy and the local production of migration inhibition factor and interleukin 1. Am J Pathol (1985) 1.07
Development of of macrophage migration inhibition in rabbits infected with virulent Treponema pallidum. Infect Immun (1977) 1.04
Infectious mononucleosis and mononucleosis syndromes. West J Med (1977) 1.02
A study of the efficacy of typhoid vaccine in inducing humoral and cell-mediated immune responses in human volunteers. Clin Exp Immunol (1977) 0.99
Lymphocyte dysfunction after DNA damage by toxic oxygen species. A model of immunodeficiency. J Exp Med (1986) 0.99
Nonspecific suppressive effect of bovine herpesvirus type 1 on bovine leukocyte functions. Infect Immun (1983) 0.99
Distemper virus infection in ferrets: an animal model of measles-induced immunosuppression. Clin Exp Immunol (1982) 0.95
Sequential studies of lymphocyte responsiveness and antibody formation in acute bacterial meningitis. Clin Exp Immunol (1976) 0.94
Levamisole exacerbates coxsackievirus B3-induced murine myocarditis. Infect Immun (1983) 0.93
Defect in the generation of cytotoxic T cells in lepromatous leprosy. Clin Exp Immunol (1982) 0.92
In vitro reversal of cellular unresponsiveness induced by levamisole. Clin Exp Immunol (1976) 0.91
Anergy-like immunosuppression in mice bearing pulmonary foreign-body granulomatous inflammation. Am J Pathol (1985) 0.91
T lymphoid cells in primary syphilis. Quantitative studies. Br J Vener Dis (1980) 0.88
Basophils in tuberculin and "Jones-Mote" delayed reactions of humans. J Clin Invest (1976) 0.85
Autolymphocytotoxins in syphilis. Br J Vener Dis (1980) 0.84
Serum inhibitory factors (SIF) in patients with acute and chronic hepatitis and their clinical significance. Clin Exp Immunol (1976) 0.83
Accelerated lesion development in experimental syphilis. Infect Immun (1981) 0.82
Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease. Clin Exp Immunol (1978) 0.81
Mitogen responsiveness in viral hepatitis and chronic active hepatitis: the role of reversible suppressive influences. Gut (1980) 0.81
Suppressor and helper T-cell populations in Mycobacterium kansasii-infected spleens. Immunology (1981) 0.79
Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. The significance of serum inhibition and rosette inhibitory factors. Clin Exp Immunol (1979) 0.78
Cellular immunity and nutrition in refractory disseminated blastomycosis. Can Med Assoc J (1978) 0.77
Depression of cell-mediated immunity in cholera. Infect Immun (1979) 0.75
Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science (1990) 7.33
Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect Immun (1994) 3.59
Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect Immun (1992) 3.04
Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci U S A (1992) 2.99
Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease. J Immunol (1991) 2.61
Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection. J Immunol (1992) 2.49
Mitochondrial antibody in primary biliary cirrhosis and other diseases. Ann Intern Med (1972) 2.15
Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B. Proc Natl Acad Sci U S A (1993) 1.84
Long-term protection of mice from Lyme disease by vaccination with OspA. Infect Immun (1992) 1.75
Depression of cell-mediated immunity during acute infectious mononucleosis. N Engl J Med (1974) 1.74
Regulation of delayed hypersensitivity. Failure to transfer delayed hypersensitivity to desensitized guinea pigs. J Exp Med (1973) 1.66
Immune evasion by tickborne and host-adapted Borrelia burgdorferi. J Infect Dis (1998) 1.52
The effect of plasma upon lymphocyte response in vitro. Demonstration of a humoral inhibitor in patients with sarcoidosis. Clin Exp Immunol (1974) 1.51
Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands. J Infect Dis (2001) 1.45
Prevention of Borrelia burgdorferi transmission in guinea pigs by tick immunity. Am J Trop Med Hyg (1998) 1.40
Novel Borrelia burgdorferi isolates from Ixodes scapularis and Ixodes dentatus ticks feeding on humans. J Clin Microbiol (1996) 1.31
Intestinal antibodies to wheat fractions in celiac disease. Ann Intern Med (1968) 1.30
The immunological competence of subjects with sarcoidosis. Clin Exp Immunol (1974) 1.26
Depression of established delayed hepersensitivity by mumps virus. J Immunol (1972) 1.16
Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J Infect Dis (1991) 1.14
Delayed hypersensitivity reactions in normal and bursectomized chickens. Int Arch Allergy Appl Immunol (1971) 1.11
Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. J Exp Med (1995) 1.07
Borrelia burgdorferi infection and immunity in mice deficient in the fifth component of complement. Infect Immun (1993) 1.06
In vivo suppression of delayed hypersensitivity: prolongation of desensitization in guinea pigs. J Exp Med (1975) 1.02
Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice. J Immunol (1993) 1.01
Depressed lymphocyte function after measles-mumps-rubella vaccination. J Infect Dis (1975) 1.01
Reticuloendothelial function in pregnancy. Yale J Biol Med (1966) 0.99
Local passive transfer of delayed-type hypersensitivity in the mouse. J Immunol (1982) 0.97
Serological diagnosis of primary biliary cirrhosis: a potential clue to pathogenesis. Trans Assoc Am Physicians (1967) 0.90
Nerve stimulation test in murine experimental autoimmune myasthenia gravis. Ann Neurol (1982) 0.90
Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice. J Immunol (1996) 0.89
Delayed hypersensitivity. II. Persistence and conjugate specificity of the transfer reaction. J Immunol (1968) 0.86
Efficacy of human Lyme disease vaccine formulations in a mouse model. J Infect Dis (1995) 0.86
Protective immunity in lyme borreliosis. Parasitol Today (1993) 0.85
Effects of pharmacological inhibition of histamine synthesis upon immunological reactions in guinea-pigs. Immunology (1970) 0.83
Cellular cooperation in the expression of murine delayed-type hypersensitivity (DTH). 1. A normal accessory cell population enhances DTH produced by immune peritoneal exudate T lymphocytes. Cell Immunol (1985) 0.83
Comparison of the anergy of sarcoidosis with experimentally induced anergy in guinea pigs. Ann N Y Acad Sci (1976) 0.83
Granulocytic ehrlichiosis in tick-immune guinea pigs. Infect Immun (1998) 0.83
Delayed hypersensitivity. I. Effect of in vitro exposure of cells to antigen upon leukocytic transfer of delayed hypersensitivity. J Exp Med (1968) 0.82
Hapten-protein conjugates as antigens for evaluation of immune competence in man. I. Reactive haptens versus conjugate. J Allergy (1969) 0.82
SALP16, a gene induced in Ixodes scapularis salivary glands during tick feeding. Am J Trop Med Hyg (2000) 0.82
Letter: Decreased circulating T cells during viral pharyngitis. Ann Intern Med (1974) 0.82
A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in 'antibody-negative' myasthenia gravis. J Neuroimmunol (1990) 0.81
A canine distemper model of virus-induced anergy. J Infect Dis (1976) 0.80
Delayed hypersensitivity. 3. Effect of pre-exposure to antigen upon macrophage migration. J Immunol (1969) 0.80
The relation of clinical disease to antibody titre, proliferative response and neurophysiology in murine experimental autoimmune myasthenia gravis. Clin Exp Immunol (1983) 0.79
Sarcoid. J Invest Dermatol (1976) 0.79
Desensitization in mice: T-cell requirement for nonspecific suppression of delayed-type hypersensitivity. Cell Immunol (1981) 0.78
In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis. Clin Exp Immunol (1984) 0.78
Delayed hypersensitivity. IV. Hapten-specific delayed reactions; interaction of immune serum and sensitized cells. J Immunol (1970) 0.78
Helper T-cell lines specific for the acetylcholine receptor: induction, characterization, and in vitro effects. Clin Immunol Immunopathol (1985) 0.77
An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides. Immunol Lett (1989) 0.77
Serum complement in eclamptogenic toxemia. Am J Obstet Gynecol (1966) 0.76
The multiple mixed lymphocyte reaction: variables important in the test as a measure of lymphocyte competence in man. Yale J Biol Med (1975) 0.76
Steroid amelioration of immunogenic insulin-resistant diabetes: a proposed mechanism. Yale J Biol Med (1967) 0.75
Suppressor T-cell lines and hybridomas in murine myasthenia. Ann N Y Acad Sci (1987) 0.75
Short-term storage of human lymphocytes prior to in vitro stimulation. Transplantation (1974) 0.75